Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

Moderna, Inc. Director's Dealing 2024

Aug 7, 2024

30610_dirs_2024-08-07_daf5a933-e4fe-44b5-8cb8-b330fee563ce.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Moderna, Inc. (MRNA)
CIK: 0001682852
Period of Report: 2024-08-05

Reporting Person: Rubenstein David M. (Director)

More from Moderna, Inc.

Regulatory Filings 2026
May 11
Director's Dealing 2026
Mar 3
Director's Dealing 2026
Mar 3
Director's Dealing 2026
Mar 3
Director's Dealing 2026
Mar 3
Director's Dealing 2026
Feb 25
Regulatory Filings 2026
Feb 23
Annual Report 2026
Feb 20
Director's Dealing 2026
Feb 13
Director's Dealing 2026
Feb 13
View all filings →